2qlq: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
2QLQ is a | 2QLQ is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Gallus_gallus Gallus gallus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2QLQ OCA]. | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:18316192</ref><references group="xtra"/> | |||
[[Category: Gallus gallus]] | [[Category: Gallus gallus]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] | ||
[[Category: Gruetter, C.]] | [[Category: Gruetter, C.]] | ||
[[Category: Michalczyk, A.]] | [[Category: Michalczyk, A.]] | ||
| Line 47: | Line 46: | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 18 08:00:37 2009'' | ||
Revision as of 06:00, 18 February 2009
Crystal structure of src kinase with covalent inhibitor XXX
Template:ABSTRACT PUBMED 18316192
About this Structure
2QLQ is a 2 chains structure of sequences from Gallus gallus. Full crystallographic information is available from OCA.
Reference
- Michalczyk A, Kluter S, Rode HB, Simard JR, Grutter C, Rabiller M, Rauh D. Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR. Bioorg Med Chem. 2008 Apr 1;16(7):3482-8. Epub 2008 Feb 20. PMID:18316192 doi:10.1016/j.bmc.2008.02.053
Page seeded by OCA on Wed Feb 18 08:00:37 2009
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Pages with broken file links
- Gallus gallus
- Non-specific protein-tyrosine kinase
- Gruetter, C.
- Michalczyk, A.
- Rauh, D.
- Rode, H B.
- Alternative splicing
- Atp-binding
- Drug resistance
- Irreversible inhibitor
- Kovalent inhibitor
- Lipoprotein
- Myristate
- Nucleotide-binding
- Phosphorylation
- Proto-oncogene
- Sh2 domain
- Sh3 domain
- Src kinase domain
- Transferase
- Tyrosine-protein kinase
